English

InspireMD, Inc.

EDGAR

NSPR Quarterly report (10-Q) · filed 2026-08-14

Annual consolidated revenue for 2025: about USD 8.979M, using the latest reported figures. The previous period, 2024, was about USD 7.009M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.77 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 1771000 USD Source

Operating margin

-815.64%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -14445000 USD Source
Revenue: 1771000 USD Source

Operating cash flow

-10.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -23232000 USD Source
Operating Cash Flow: -12337000 USD Source

Free cash flow

-11.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -23232000 USD Source
Operating Cash Flow: -12337000 USD Source
Capital Expenditure: 524000 USD Source
Capital Expenditure: 194000 USD Source

Cash and cash equivalents: 15.1 million USD 2026-06-30 Source
Exact value

15149000 USD
Long-term debt including current maturities: 5.01 million USD 2015-12-31 Source
Exact value

5010000 USD
Shares outstanding: 46.9 million shares 2026-06-30 Source
Exact value

46921061 shares

Reported share-count change

44.14% · 14.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

32552888 shares · 2025-06-30· Source
46921061 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

10.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 2523000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 8979000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 5830000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 3398000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 1771000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-52.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -12708000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -48786000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -37025000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -13689000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -14324000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-41.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -25758000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -17125000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -35103000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -25758000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -12337000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -23232000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -12337000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

1.25 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 1264000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 935000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1662000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1264000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 194000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 524000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 194000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-42.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -25758000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -17125000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -35103000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -25758000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -12337000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -23232000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -12337000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 1264000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 935000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1662000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1264000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 194000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 524000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 194000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+28.1%

Prior period

USD 7.01 million

2024-01-01 – 2024-12-31
Current period

USD 8.98 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

8979000 − 7009000 = 1970000 USD

7009000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
8979000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Year-over-year change in Revenue: 1970000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8979000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2314965 Filing: 000149315226010886 Input fundies:Revenue: 7009000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2315634 Filing: 000149315226010886
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 16.78 million

Prior period

−USD 32.01 million

2024-01-01 – 2024-12-31
Current period

−USD 48.79 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-48786000 − -32005000 = -16781000 USD

-32005000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-48786000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Year-over-year change in Net income: -16781000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -48786000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2354765 Filing: 000149315226010886 Input fundies:NetIncome: -32005000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2355473 Filing: 000149315226010886
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 13.24 million

Prior period

−USD 21.87 million

2024-01-01 – 2024-12-31
Current period

−USD 35.1 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-35103000 − -21868000 = -13235000 USD

-21868000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-35103000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Year-over-year change in Operating cash flow: -13235000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -35103000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1616427 Filing: 000149315226010886 Input fundies:OperatingCashFlow: -21868000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1617105 Filing: 000149315226010886
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+18.5%

Prior period

USD 1.4 million

2024-01-01 – 2024-12-31
Current period

USD 1.66 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1662000 − 1402000 = 260000 USD

1402000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1662000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Year-over-year change in Capital expenditure: 260000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1662000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619171 Filing: 000149315226010886 Input fundies:CapitalExpenditure: 1402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619775 Filing: 000149315226010886
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 8.98 million 100% of revenue
Cost of revenue USD 6.33 million 70% of revenue
Operating expenses USD 52.26 million 582% of revenue
Operating income −USD 49.61 million −553% of revenue
Tax, interest and other Derived −USD 828,000 −9.2% of revenue
Net income −USD 48.79 million −543% of revenue

Cash

Operating cash flow −USD 35.1 million −391% of revenue
Capital expenditure USD 1.66 million 19% of revenue
Free cash flow Derived −USD 36.77 million −409% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 504% of revenue.
2017 Operating loss: operating costs were 398% of revenue.
2018 Operating loss: operating costs were 311% of revenue.
2019 Operating loss: operating costs were 364% of revenue.
2020 Operating loss: operating costs were 518% of revenue.
2021 Operating loss: operating costs were 427% of revenue.
2022 Operating loss: operating costs were 462% of revenue.
2023 Operating loss: operating costs were 441% of revenue.
2024 Operating loss: operating costs were 578% of revenue.
2025 Operating loss: operating costs were 653% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1894000	9542000 Derived	-7648000	813000 Derived	-8461000	-7544000 Derived	Source 2016-01-01 – 2016-12-31: 1894000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -7648000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -8461000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -7495000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 49000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	2761000	10993000 Derived	-8232000	206000 Derived	-8438000	-8389000 Derived	Source 2017-01-01 – 2017-12-31: 2761000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -8232000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -8438000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -8131000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 258000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	3601000	11212000 Derived	-7611000	-371000 Derived	-7240000	-7673000 Derived	Source 2018-01-01 – 2018-12-31: 3601000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7611000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -7240000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7606000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 67000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	3721000	13537000 Derived	-9816000	224000 Derived	-10040000	-10094000 Derived	Source 2019-01-01 – 2019-12-31: 3721000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -9816000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -10040000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -9810000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 284000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2485000	12865000 Derived	-10380000	164000 Derived	-10544000	-9169000 Derived	Source 2020-01-01 – 2020-12-31: 2485000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -10380000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -10544000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -9081000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 88000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	4495000	19211000 Derived	-14716000	202000 Derived	-14918000	-13554000 Derived	Source 2021-01-01 – 2021-12-31: 4495000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -14716000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -14918000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -13210000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 344000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	5171000	23884000 Derived	-18713000	-222000 Derived	-18491000	-16015000 Derived	Source 2022-01-01 – 2022-12-31: 5171000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -18713000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -18491000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -15542000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 473000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	6205000	27348000 Derived	-21143000	-1227000 Derived	-19916000	-16757000 Derived	Source 2023-01-01 – 2023-12-31: 6205000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -21143000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -19916000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -16376000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 381000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	7009000	40512000 Derived	-33503000	-1498000 Derived	-32005000	-23270000 Derived	Source 2024-01-01 – 2024-12-31: 7009000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -33503000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -32005000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -21868000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1402000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	8979000	58593000 Derived	-49614000	-828000 Derived	-48786000	-36765000 Derived	Source 2025-01-01 – 2025-12-31: 8979000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -49614000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -48786000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -35103000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 1662000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	1894000	Revenue: 1894000 Open source
20172017-12-31	Revenue	2761000	Revenue: 2761000 Open source
20182018-12-31	Revenue	3601000	Revenue: 3601000 Open source
20192019-12-31	Revenue	3721000	Revenue: 3721000 Open source
20202020-12-31	Revenue	2485000	Revenue: 2485000 Open source
20212021-12-31	Revenue	4495000	Revenue: 4495000 Open source
20222022-12-31	Revenue	5171000	Revenue: 5171000 Open source
20232023-12-31	Revenue	6205000	Revenue: 6205000 Open source
20242024-12-31	Revenue	7009000	Revenue: 7009000 Open source
20252025-12-31	Revenue	8979000	Revenue: 8979000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

28.1% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-18%	Revenue: 1894000 Open source Revenue: 2310000 Open source
20172017-12-31	Year over year	45.8%	Revenue: 2761000 Open source Revenue: 1894000 Open source
20182018-12-31	Year over year	30.4%	Revenue: 3601000 Open source Revenue: 2761000 Open source
20192019-12-31	Year over year	3.3%	Revenue: 3721000 Open source Revenue: 3601000 Open source
20202020-12-31	Year over year	-33.2%	Revenue: 2485000 Open source Revenue: 3721000 Open source
20212021-12-31	Year over year	80.9%	Revenue: 4495000 Open source Revenue: 2485000 Open source
20222022-12-31	Year over year	15%	Revenue: 5171000 Open source Revenue: 4495000 Open source
20232023-12-31	Year over year	20%	Revenue: 6205000 Open source Revenue: 5171000 Open source
20242024-12-31	Year over year	13%	Revenue: 7009000 Open source Revenue: 6205000 Open source
20252025-12-31	Year over year	28.1%	Revenue: 8979000 Open source Revenue: 7009000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -552.6% 2025

Net margin -543.3% 2025

Free cash flow margin -409.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-403.8%	Operating Income: -7648000 Open source Revenue: 1894000 Open source
20172017-12-31	Operating margin	-298.2%	Operating Income: -8232000 Open source Revenue: 2761000 Open source
20182018-12-31	Operating margin	-211.4%	Operating Income: -7611000 Open source Revenue: 3601000 Open source
20192019-12-31	Operating margin	-263.8%	Operating Income: -9816000 Open source Revenue: 3721000 Open source
20202020-12-31	Operating margin	-417.7%	Operating Income: -10380000 Open source Revenue: 2485000 Open source
20212021-12-31	Operating margin	-327.4%	Operating Income: -14716000 Open source Revenue: 4495000 Open source
20222022-12-31	Operating margin	-361.9%	Operating Income: -18713000 Open source Revenue: 5171000 Open source
20232023-12-31	Operating margin	-340.7%	Operating Income: -21143000 Open source Revenue: 6205000 Open source
20242024-12-31	Operating margin	-478%	Operating Income: -33503000 Open source Revenue: 7009000 Open source
20252025-12-31	Operating margin	-552.6%	Operating Income: -49614000 Open source Revenue: 8979000 Open source
20162016-12-31	Net margin	-446.7%	Net Income: -8461000 Open source Revenue: 1894000 Open source
20172017-12-31	Net margin	-305.6%	Net Income: -8438000 Open source Revenue: 2761000 Open source
20182018-12-31	Net margin	-201.1%	Net Income: -7240000 Open source Revenue: 3601000 Open source
20192019-12-31	Net margin	-269.8%	Net Income: -10040000 Open source Revenue: 3721000 Open source
20202020-12-31	Net margin	-424.3%	Net Income: -10544000 Open source Revenue: 2485000 Open source
20212021-12-31	Net margin	-331.9%	Net Income: -14918000 Open source Revenue: 4495000 Open source
20222022-12-31	Net margin	-357.6%	Net Income: -18491000 Open source Revenue: 5171000 Open source
20232023-12-31	Net margin	-321%	Net Income: -19916000 Open source Revenue: 6205000 Open source
20242024-12-31	Net margin	-456.6%	Net Income: -32005000 Open source Revenue: 7009000 Open source
20252025-12-31	Net margin	-543.3%	Net Income: -48786000 Open source Revenue: 8979000 Open source
20162016-12-31	Free cash flow margin	-398.3%	Revenue: 1894000 Open source Operating Cash Flow: -7495000 Open source Capital Expenditure: 49000 Open source
20172017-12-31	Free cash flow margin	-303.8%	Revenue: 2761000 Open source Operating Cash Flow: -8131000 Open source Capital Expenditure: 258000 Open source
20182018-12-31	Free cash flow margin	-213.1%	Revenue: 3601000 Open source Operating Cash Flow: -7606000 Open source Capital Expenditure: 67000 Open source
20192019-12-31	Free cash flow margin	-271.3%	Revenue: 3721000 Open source Operating Cash Flow: -9810000 Open source Capital Expenditure: 284000 Open source
20202020-12-31	Free cash flow margin	-369%	Revenue: 2485000 Open source Operating Cash Flow: -9081000 Open source Capital Expenditure: 88000 Open source
20212021-12-31	Free cash flow margin	-301.5%	Revenue: 4495000 Open source Operating Cash Flow: -13210000 Open source Capital Expenditure: 344000 Open source
20222022-12-31	Free cash flow margin	-309.7%	Revenue: 5171000 Open source Operating Cash Flow: -15542000 Open source Capital Expenditure: 473000 Open source
20232023-12-31	Free cash flow margin	-270.1%	Revenue: 6205000 Open source Operating Cash Flow: -16376000 Open source Capital Expenditure: 381000 Open source
20242024-12-31	Free cash flow margin	-332%	Revenue: 7009000 Open source Operating Cash Flow: -21868000 Open source Capital Expenditure: 1402000 Open source
20252025-12-31	Free cash flow margin	-409.5%	Revenue: 8979000 Open source Operating Cash Flow: -35103000 Open source Capital Expenditure: 1662000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -35.1M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-7495000	Operating Cash Flow: -7495000 Open source
20172017-12-31	Operating cash flow	-8131000	Operating Cash Flow: -8131000 Open source
20182018-12-31	Operating cash flow	-7606000	Operating Cash Flow: -7606000 Open source
20192019-12-31	Operating cash flow	-9810000	Operating Cash Flow: -9810000 Open source
20202020-12-31	Operating cash flow	-9081000	Operating Cash Flow: -9081000 Open source
20212021-12-31	Operating cash flow	-13210000	Operating Cash Flow: -13210000 Open source
20222022-12-31	Operating cash flow	-15542000	Operating Cash Flow: -15542000 Open source
20232023-12-31	Operating cash flow	-16376000	Operating Cash Flow: -16376000 Open source
20242024-12-31	Operating cash flow	-21868000	Operating Cash Flow: -21868000 Open source
20252025-12-31	Operating cash flow	-35103000	Operating Cash Flow: -35103000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -36.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-7544000	Operating Cash Flow: -7495000 Open source Capital Expenditure: 49000 Open source
20172017-12-31	Free cash flow	-8389000	Operating Cash Flow: -8131000 Open source Capital Expenditure: 258000 Open source
20182018-12-31	Free cash flow	-7673000	Operating Cash Flow: -7606000 Open source Capital Expenditure: 67000 Open source
20192019-12-31	Free cash flow	-10094000	Operating Cash Flow: -9810000 Open source Capital Expenditure: 284000 Open source
20202020-12-31	Free cash flow	-9169000	Operating Cash Flow: -9081000 Open source Capital Expenditure: 88000 Open source
20212021-12-31	Free cash flow	-13554000	Operating Cash Flow: -13210000 Open source Capital Expenditure: 344000 Open source
20222022-12-31	Free cash flow	-16015000	Operating Cash Flow: -15542000 Open source Capital Expenditure: 473000 Open source
20232023-12-31	Free cash flow	-16757000	Operating Cash Flow: -16376000 Open source Capital Expenditure: 381000 Open source
20242024-12-31	Free cash flow	-23270000	Operating Cash Flow: -21868000 Open source Capital Expenditure: 1402000 Open source
20252025-12-31	Free cash flow	-36765000	Operating Cash Flow: -35103000 Open source Capital Expenditure: 1662000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

20.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	57%	Total Liabilities: 5365000 Open source Total Assets: 9410000 Open source
20172017-12-31	Liabilities / assets	50.9%	Total Liabilities: 3106000 Open source Total Assets: 6107000 Open source
20182018-12-31	Liabilities / assets	28.7%	Total Liabilities: 3525000 Open source Total Assets: 12288000 Open source
20192019-12-31	Liabilities / assets	45.5%	Total Liabilities: 4497000 Open source Total Assets: 9880000 Open source
20202020-12-31	Liabilities / assets	31.6%	Total Liabilities: 5614000 Open source Total Assets: 17777000 Open source
20212021-12-31	Liabilities / assets	15.6%	Total Liabilities: 6180000 Open source Total Assets: 39712000 Open source
20222022-12-31	Liabilities / assets	29.4%	Total Liabilities: 7260000 Open source Total Assets: 24653000 Open source
20232023-12-31	Liabilities / assets	17.1%	Total Liabilities: 8142000 Open source Total Assets: 47643000 Open source
20242024-12-31	Liabilities / assets	22.9%	Total Liabilities: 10721000 Open source Total Assets: 46807000 Open source
20252025-12-31	Liabilities / assets	20.5%	Total Liabilities: 14203000 Open source Total Assets: 69404000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.74× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	1.81×	Current Assets: 8632000 Open source Current Liabilities: 4778000 Open source
20172017-12-31	Current assets / current liabilities	2.08×	Current Assets: 5155000 Open source Current Liabilities: 2482000 Open source
20182018-12-31	Current assets / current liabilities	3.91×	Current Assets: 11419000 Open source Current Liabilities: 2920000 Open source
20192019-12-31	Current assets / current liabilities	2.51×	Current Assets: 7810000 Open source Current Liabilities: 3115000 Open source
20202020-12-31	Current assets / current liabilities	4.14×	Current Assets: 15339000 Open source Current Liabilities: 3705000 Open source
20212021-12-31	Current assets / current liabilities	8.53×	Current Assets: 37094000 Open source Current Liabilities: 4347000 Open source
20222022-12-31	Current assets / current liabilities	4.21×	Current Assets: 21326000 Open source Current Liabilities: 5070000 Open source
20232023-12-31	Current assets / current liabilities	7.34×	Current Assets: 44159000 Open source Current Liabilities: 6020000 Open source
20242024-12-31	Current assets / current liabilities	5.28×	Current Assets: 40521000 Open source Current Liabilities: 7678000 Open source
20252025-12-31	Current assets / current liabilities	5.74×	Current Assets: 61471000 Open source Current Liabilities: 10712000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 8.46 million Exact value Exact value: -8461000 USD 2016-01-01 – 2016-12-31: -8461000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2016-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -8461000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8461000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315218001974/nspr-20171231.xml#162224 Filing: 000149315218001974 The citation records this snapshot. The page link may show a newer release later.	−USD 7.5 million Exact value Exact value: -7495000 USD 2016-01-01 – 2016-12-31: -7495000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2016-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -7495000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7495000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315218001974/nspr-20171231.xml#684010 Filing: 000149315218001974 The citation records this snapshot. The page link may show a newer release later.	USD 49,000 Exact value Exact value: 49000 USD 2016-01-01 – 2016-12-31: 49000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2016-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 49000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315218001974/nspr-20171231.xml#692242 Filing: 000149315218001974 The citation records this snapshot. The page link may show a newer release later.	−USD 7.54 million Calculation and evidence -7495000 − 49000 USD Exact free cash flow: -7544000 USD 2016-01-01 – 2016-12-31: -7495000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 49000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2016-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -7544000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7495000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315218001974/nspr-20171231.xml#684010 Filing: 000149315218001974 Input fundies:CapitalExpenditure: 49000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315218001974/nspr-20171231.xml#692242 Filing: 000149315218001974 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 8.44 million Exact value Exact value: -8438000 USD 2017-01-01 – 2017-12-31: -8438000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2017-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -8438000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8438000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/nspr-20181231.xml#185071 Filing: 000149315219002225 The citation records this snapshot. The page link may show a newer release later.	−USD 8.13 million Exact value Exact value: -8131000 USD 2017-01-01 – 2017-12-31: -8131000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2017-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -8131000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8131000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/nspr-20181231.xml#246398 Filing: 000149315219002225 The citation records this snapshot. The page link may show a newer release later.	USD 258,000 Exact value Exact value: 258000 USD 2017-01-01 – 2017-12-31: 258000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2017-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 258000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 258000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/nspr-20181231.xml#221792 Filing: 000149315219002225 The citation records this snapshot. The page link may show a newer release later.	−USD 8.39 million Calculation and evidence -8131000 − 258000 USD Exact free cash flow: -8389000 USD 2017-01-01 – 2017-12-31: -8131000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 258000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2017-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -8389000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8131000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/nspr-20181231.xml#246398 Filing: 000149315219002225 Input fundies:CapitalExpenditure: 258000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/nspr-20181231.xml#221792 Filing: 000149315219002225 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 7.24 million Exact value Exact value: -7240000 USD 2018-01-01 – 2018-12-31: -7240000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2018-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -7240000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7240000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/nspr-20191231.xml#157277 Filing: 000149315220003630 The citation records this snapshot. The page link may show a newer release later.	−USD 7.61 million Exact value Exact value: -7606000 USD 2018-01-01 – 2018-12-31: -7606000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2018-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -7606000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7606000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/nspr-20191231.xml#181048 Filing: 000149315220003630 The citation records this snapshot. The page link may show a newer release later.	USD 67,000 Exact value Exact value: 67000 USD 2018-01-01 – 2018-12-31: 67000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2018-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 67000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 67000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/nspr-20191231.xml#168298 Filing: 000149315220003630 The citation records this snapshot. The page link may show a newer release later.	−USD 7.67 million Calculation and evidence -7606000 − 67000 USD Exact free cash flow: -7673000 USD 2018-01-01 – 2018-12-31: -7606000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 67000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2018-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -7673000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7606000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/nspr-20191231.xml#181048 Filing: 000149315220003630 Input fundies:CapitalExpenditure: 67000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/nspr-20191231.xml#168298 Filing: 000149315220003630 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 10.04 million Exact value Exact value: -10040000 USD 2019-01-01 – 2019-12-31: -10040000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2019-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -10040000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10040000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315221005564/nspr-20201231.xml#143059 Filing: 000149315221005564 The citation records this snapshot. The page link may show a newer release later.	−USD 9.81 million Exact value Exact value: -9810000 USD 2019-01-01 – 2019-12-31: -9810000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2019-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -9810000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9810000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315221005564/nspr-20201231.xml#175377 Filing: 000149315221005564 The citation records this snapshot. The page link may show a newer release later.	USD 284,000 Exact value Exact value: 284000 USD 2019-01-01 – 2019-12-31: 284000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2019-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 284000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 284000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315221005564/nspr-20201231.xml#175007 Filing: 000149315221005564 The citation records this snapshot. The page link may show a newer release later.	−USD 10.09 million Calculation and evidence -9810000 − 284000 USD Exact free cash flow: -10094000 USD 2019-01-01 – 2019-12-31: -9810000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 284000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2019-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -10094000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9810000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315221005564/nspr-20201231.xml#175377 Filing: 000149315221005564 Input fundies:CapitalExpenditure: 284000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315221005564/nspr-20201231.xml#175007 Filing: 000149315221005564 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 10.54 million Exact value Exact value: -10544000 USD 2020-01-01 – 2020-12-31: -10544000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2020-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -10544000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10544000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315222006180/form10-k.htm#1692675 Filing: 000149315222006180 The citation records this snapshot. The page link may show a newer release later.	−USD 9.08 million Exact value Exact value: -9081000 USD 2020-01-01 – 2020-12-31: -9081000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2020-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -9081000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9081000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315222006180/form10-k.htm#1708459 Filing: 000149315222006180 The citation records this snapshot. The page link may show a newer release later.	USD 88,000 Exact value Exact value: 88000 USD 2020-01-01 – 2020-12-31: 88000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2020-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 88000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 88000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315222006180/form10-k.htm#1709960 Filing: 000149315222006180 The citation records this snapshot. The page link may show a newer release later.	−USD 9.17 million Calculation and evidence -9081000 − 88000 USD Exact free cash flow: -9169000 USD 2020-01-01 – 2020-12-31: -9081000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 88000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2020-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -9169000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9081000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315222006180/form10-k.htm#1708459 Filing: 000149315222006180 Input fundies:CapitalExpenditure: 88000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315222006180/form10-k.htm#1709960 Filing: 000149315222006180 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 14.92 million Exact value Exact value: -14918000 USD 2021-01-01 – 2021-12-31: -14918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2021-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -14918000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14918000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315223009598/form10-k.htm#1689871 Filing: 000149315223009598 The citation records this snapshot. The page link may show a newer release later.	−USD 13.21 million Exact value Exact value: -13210000 USD 2021-01-01 – 2021-12-31: -13210000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2021-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -13210000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13210000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315223009598/form10-k.htm#1722780 Filing: 000149315223009598 The citation records this snapshot. The page link may show a newer release later.	USD 344,000 Exact value Exact value: 344000 USD 2021-01-01 – 2021-12-31: 344000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2021-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 344000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 344000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315223009598/form10-k.htm#1726350 Filing: 000149315223009598 The citation records this snapshot. The page link may show a newer release later.	−USD 13.55 million Calculation and evidence -13210000 − 344000 USD Exact free cash flow: -13554000 USD 2021-01-01 – 2021-12-31: -13210000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 344000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2021-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -13554000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13210000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315223009598/form10-k.htm#1722780 Filing: 000149315223009598 Input fundies:CapitalExpenditure: 344000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315223009598/form10-k.htm#1726350 Filing: 000149315223009598 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 18.49 million Exact value Exact value: -18491000 USD 2022-01-01 – 2022-12-31: -18491000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2022-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -18491000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18491000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315224008850/form10-k.htm#1391203 Filing: 000149315224008850 The citation records this snapshot. The page link may show a newer release later.	−USD 15.54 million Exact value Exact value: -15542000 USD 2022-01-01 – 2022-12-31: -15542000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2022-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -15542000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15542000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315224008850/form10-k.htm#1407839 Filing: 000149315224008850 The citation records this snapshot. The page link may show a newer release later.	USD 473,000 Exact value Exact value: 473000 USD 2022-01-01 – 2022-12-31: 473000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2022-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 473000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 473000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315224008850/form10-k.htm#1409362 Filing: 000149315224008850 The citation records this snapshot. The page link may show a newer release later.	−USD 16.02 million Calculation and evidence -15542000 − 473000 USD Exact free cash flow: -16015000 USD 2022-01-01 – 2022-12-31: -15542000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 473000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2022-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -16015000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15542000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315224008850/form10-k.htm#1407839 Filing: 000149315224008850 Input fundies:CapitalExpenditure: 473000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315224008850/form10-k.htm#1409362 Filing: 000149315224008850 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 19.92 million Exact value Exact value: -19916000 USD 2023-01-01 – 2023-12-31: -19916000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2023-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -19916000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19916000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315225009909/form10-k.htm#2268415 Filing: 000149315225009909 The citation records this snapshot. The page link may show a newer release later.	−USD 16.38 million Exact value Exact value: -16376000 USD 2023-01-01 – 2023-12-31: -16376000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2023-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -16376000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16376000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315225009909/form10-k.htm#1517860 Filing: 000149315225009909 The citation records this snapshot. The page link may show a newer release later.	USD 381,000 Exact value Exact value: 381000 USD 2023-01-01 – 2023-12-31: 381000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2023-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 381000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315225009909/form10-k.htm#1520545 Filing: 000149315225009909 The citation records this snapshot. The page link may show a newer release later.	−USD 16.76 million Calculation and evidence -16376000 − 381000 USD Exact free cash flow: -16757000 USD 2023-01-01 – 2023-12-31: -16376000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 381000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2023-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -16757000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16376000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315225009909/form10-k.htm#1517860 Filing: 000149315225009909 Input fundies:CapitalExpenditure: 381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315225009909/form10-k.htm#1520545 Filing: 000149315225009909 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 32.01 million Exact value Exact value: -32005000 USD 2024-01-01 – 2024-12-31: -32005000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2024-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -32005000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32005000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2355473 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	−USD 21.87 million Exact value Exact value: -21868000 USD 2024-01-01 – 2024-12-31: -21868000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2024-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -21868000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21868000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1617105 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	USD 1.4 million Exact value Exact value: 1402000 USD 2024-01-01 – 2024-12-31: 1402000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2024-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 1402000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619775 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	−USD 23.27 million Calculation and evidence -21868000 − 1402000 USD Exact free cash flow: -23270000 USD 2024-01-01 – 2024-12-31: -21868000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1402000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2024-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -23270000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21868000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1617105 Filing: 000149315226010886 Input fundies:CapitalExpenditure: 1402000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619775 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 48.79 million Exact value Exact value: -48786000 USD 2025-01-01 – 2025-12-31: -48786000 USD Inspect Net Income Open source Share or cite Citation for Net Income · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Net Income: -48786000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48786000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#2354765 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	−USD 35.1 million Exact value Exact value: -35103000 USD 2025-01-01 – 2025-12-31: -35103000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Operating Cash Flow: -35103000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35103000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1616427 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	USD 1.66 million Exact value Exact value: 1662000 USD 2025-01-01 – 2025-12-31: 1662000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Capital Expenditure: 1662000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1662000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619171 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.	−USD 36.77 million Calculation and evidence -35103000 − 1662000 USD Exact free cash flow: -36765000 USD 2025-01-01 – 2025-12-31: -35103000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 1662000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · InspireMD, Inc. · 2025-12-31 InspireMD, Inc. (edgar:1433607) Free cash flow: -36765000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:35:27Z Snapshot: 903f51ea36cc58d4f801ec1817e3dcaa1c19ec832624db5e7ad10ef356386de9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1433607?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35103000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1616427 Filing: 000149315226010886 Input fundies:CapitalExpenditure: 1662000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/form10-k.htm#1619171 Filing: 000149315226010886 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

83 filings · 4,146 latest values · 4,146 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001433607, 1433607, NSPR, edgar:1433607, nspr

Also known as InspireMD, Inc., InspireMD, Inc., Saguaro Resources, Inc.

InspireMD, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation